Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Closure of Trading Window

 We are hereby enclosing the intimation for closure of trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Friday, January 1, 2021 up to 48 hours after declaration of financial results for the quarter ended December 31, 2020. The date of meeting of the Board of Directors, to approve the financial results of the Company for the quarter ended December 31, 2020 will be informed in due course. Accordingly all connected/ designated persons and their relative are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.
01-01-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Submission Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions on a consolidated basis for the half year ended September 30, 2020. Kindly take the above on your records.
05-12-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Updates

 We wish to inform you that CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc, Salt Lake City, Utah, USA recently got permission to manufacture COVID-19 test with two target genes (RdRP & E) from CDSCO. Like one gene test, this test is also highly specific and sensitive with fast and accurate diagnosis of COVID-19 infection with precise accuracy. This is one more step towards commitment of providing diagnostic kits helpful in early diagnosis, evaluation and management of treatment. You are requested to take the same on your record.
26-11-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of SEBI(LODR) Regulations,2015 - Outcome Of The Meeting Of Internal Finance Committee Of Board Held On 26.11.2020

 The Internal Finance Committee of Board in its meeting held on 26th November, 2020 has agreed to enter in to Share Purchase Agreement (SPA) with Asence Pharma Private Limited for sale/transfer of up to 100% of equity shares of Synbiotics Limited, a wholly owned subsidiary of the Company, as approved by the members of the Company at their 42nd Annual General Meeting of the Company held on 30th September, 2020. We are hereby enclosing the detailed outcome of the meeting of Internal Finance Committee of Board held on 26.11.2020. You are requested to take the same on your record.
26-11-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Results - Financial Results For The Quarter And Half Year Ended September 30, 2020

 Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 10th November, 2020, has considered, approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on 30th September, 2020 along with Limited Review Report by Auditors thereon. In this regard, please find enclosed herewith the following: A. Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on 30th September, 2020; and B. Limited Review Report issued by the Statutory Auditors of the Company. You are requested to take the same on your record and oblige.
10-11-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Outcome Of Board Meeting Held On November 10, 2020

 Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 10th November, 2020, has considered, approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on 30th September, 2020 along with Limited Review Report by Auditors thereon. In this regard, please find enclosed herewith the following: A. Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended on 30th September, 2020; and B. Limited Review Report issued by the Statutory Auditors of the Company. You are requested to take the same on your record and oblige.
10-11-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter & Half Year Ended On September 30, 2020.

 AMBALAL SARABHAI ENTERPRISES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 10, 2020, inter-alia, to transact the following: 1. To consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the Quarter & Half Year ended September 30, 2020. 2. Any other matter as the Board of Directors of the Company may decide during the course of the Meeting. Further, in continuation of our intimation dated September 30, 2020 and pursuant to Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from September 30, 2020 to November 12, 2020 (both days inclusive). This is for your information and records.
04-11-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliance - Compliance Certificate For The Half Year Ended 30Th September, 2020

 Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") for the half year ended 30th September, 2020. We are uploading again the same alongwith covering letter.
14-10-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliance - Compliance Certificate For The Half Year Ended 30Th September, 2020

 Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") for the half year ended 30th September, 2020.
13-10-2020
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliance - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended On 30Th September, 2020.

 We herewith submit Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the half year ended on 30th September, 2020 which is given by M/s. Ajay Parikh & Associates, Company Secretaries, Ahmedabad. You are requested to take the above on record.
09-10-2020
Next Page
Close

Let's Open Free Demat Account